Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma

Despite apparently having completed surgical resection, approximately half of resected early-stage lung cancer patients relapse and die of their disease. Adjuvant chemotherapy reduces this risk by only 5% to 8%. Thus, there is a need for better identifying the drivers of relapse, who benefits from a...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Cong, Qiu, Wenjia, Li, Xiangyang, Li, Hongqing, Zhou, Ji'an, Zhu, Huili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174852/
https://www.ncbi.nlm.nih.gov/pubmed/35711845
http://dx.doi.org/10.7150/jca.69583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174852/
https://www.ncbi.nlm.nih.gov/pubmed/35711845
http://dx.doi.org/10.7150/jca.69583

Ejemplares similares